Literature DB >> 3511981

Structure, function, and molecular defects of factor IX.

A R Thompson.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3511981

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  A factor IX-deficient mouse model for hemophilia B gene therapy.

Authors:  L Wang; M Zoppè; T M Hackeng; J H Griffin; K F Lee; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.

Authors:  Divi Venkateswarlu
Journal:  Biochem Biophys Res Commun       Date:  2014-08-23       Impact factor: 3.575

3.  Diagnosis of haemophilia B using the polymerase chain reaction.

Authors:  J Reiss; U Neufeldt; K Wieland; B Zoll
Journal:  Blut       Date:  1990-01

4.  Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

5.  Factor IXPortland: a nonsense mutation (CGA to TGA) resulting in hemophilia B.

Authors:  S H Chen; C R Scott; J Schoof; E W Lovrien; K Kurachi
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

6.  An insertion within the factor IX gene: hemophilia BEl Salvador.

Authors:  S H Chen; C R Scott; J R Edson; K Kurachi
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

7.  Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation.

Authors:  L M Boccia; D Lillicrap; K Newcombe; C R Mueller
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

8.  Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

Authors:  Mikhail A Panteleev; Evgueni L Saenko; Natalya M Ananyeva; Fazoil I Ataullakhanov
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

9.  Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.

Authors:  C R Benedict; J Ryan; B Wolitzky; R Ramos; M Gerlach; P Tijburg; D Stern
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4.

Authors:  P Galeffi; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.